UK markets closed

Relief Therapeutics Holding AG (RLFTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1510+0.0020 (+1.34%)
As of 3:25PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5664.43M
Enterprise value 3484.59M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)2,433.83
Price/book (mrq)7.19
Enterprise value/revenue 31,775.05
Enterprise value/EBITDA 7-25.03

Trading information

Stock price history

Beta (5Y monthly) -22.86
52-week change 3-55.92%
S&P500 52-week change 334.52%
52-week high 30.7600
52-week low 30.1420
50-day moving average 30.1991
200-day moving average 30.2381

Share statistics

Avg vol (3-month) 34.47M
Avg vol (10-day) 34.11M
Shares outstanding 54.4B
Implied shares outstanding 6N/A
Float 2.4B
% held by insiders 19.74%
% held by institutions 129.18%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)-7,092.67%

Management effectiveness

Return on assets (ttm)-24.72%
Return on equity (ttm)-19.25%

Income statement

Revenue (ttm)273k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)76.10%
Gross profit (ttm)N/A
EBITDA -19.36M
Net income avi to common (ttm)-7.83M
Diluted EPS (ttm)-0.0030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)38.25M
Total cash per share (mrq)0.01
Total debt (mrq)891k
Total debt/equity (mrq)1.33
Current ratio (mrq)7.00
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-18.25M
Levered free cash flow (ttm)-14.87M